A detailed history of Consolidated Planning Corp transactions in Amgen Inc stock. As of the latest transaction made, Consolidated Planning Corp holds 673 shares of AMGN stock, worth $212,668. This represents 0.04% of its overall portfolio holdings.

Number of Shares
673
Holding current value
$212,668
% of portfolio
0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$262.75 - $319.31 $176,830 - $214,895
673 New
673 $210,000
Q4 2023

Feb 02, 2024

BUY
$255.7 - $288.46 $186,149 - $209,998
728 New
728 $209,000
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $96,059 - $109,930
-483 Closed
0 $0
Q3 2021

Nov 17, 2021

BUY
$212.27 - $248.7 $102,526 - $120,122
483 New
483 $103,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Consolidated Planning Corp Portfolio

Follow Consolidated Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Planning Corp with notifications on news.